November 17, 2016 - By Ruchi Gupta · 0 Comments
Neptune Technologies & Bioressources Inc (NASDAQ:NEPT) institutional sentiment increased to 1.6 in 2016 Q2. Its up 0.72, from 0.88 in 2016Q1. The ratio increased, as 8 funds increased or started new equity positions, while 5 reduced and sold equity positions in Neptune Technologies & Bioressources Inc. The funds in our partner’s database now own: 7.28 million shares, down from 7.30 million shares in 2016Q1. Also, the number of funds holding Neptune Technologies & Bioressources Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 4 Increased: 5 New Position: 3.
Neptune Technologies & Bioressources Inc. is a solution well-known provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The company has a market cap of $80.28 million. The Firm is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. It currently has negative earnings. The Company’s products include Krill-Based Nutraceutical Products, including Neptune Krill Oil , OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti.
About 168,451 shares traded hands. Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) has risen 3.00% since April 15, 2016 and is uptrending. It has underperformed by 1.62% the S&P500.
According to Zacks Investment Research, “Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process. Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the nutraceutical and pharmaceutical health and wellness market. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets, the next wave in nutritional research.”
Perceptive Advisors Llc holds 0.48% of its portfolio in Neptune Technologies & Bioressources-Ord for 6.75 million shares. Alpine Partners Vi Llc owns 148,101 shares or 0.07% of their US portfolio. Moreover, National Asset Management Inc. has 0.01% invested in the company for 60,000 shares. The Ontario – Canada-based 1832 Asset Management L.P. has invested 0% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 7,000 shares.#img1#
More news for Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) were recently published by: Seekingalpha.com, which released: “Marketing Strategy Could Distinguish Neptune With Industry-Leading Status” on March 04, 2014. Seekingalpha.com‘s article titled: “Neptune Erecting A Moat In Omega-3; Shares Undervalued” and published on January 21, 2014 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ruchi Gupta